Stifel analyst Mathew Blackman downgrades Apollo Endosurgery (NASDAQ:APEN) from Buy to Hold and announces $10 price target.
Stifel Downgrades Apollo Endosurgery to Hold, Announces $10 Price Target
Stifel analyst Mathew Blackman downgrades Apollo Endosurgery (NASDAQ:APEN) from Buy to Hold and announces $10 price target.